Lupron Depot

AbbVie Inc.🇺🇸 United States

FDA Page

Effective Date: Sep 10, 2025
Approval ID: 60aad237-e1da-4705-cbbb-b3ca79e89ad8
Products: 1 registered
Version: 1514

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use LUPRON DEPOT 11.25 mg safely and effectively. See full prescribing information for LUPRON DEPOT 11.25 mg. LUPRON DEPOT 11.25 mg (leuprolide acetate for depot suspension) for injection, for intramuscular use Initial U.S. Approval: 1985

Quick Stats

Total Products1

Labelers2

Label Sections32

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.